Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer

Intravesical infusion of chemotherapeutics is highly recommended by several clinical guidelines for treating nonmuscle invasive bladder cancer (NMIBC). However, cytotoxic chemotherapeutics can cause a series of side effects, which greatly limits their application. Herein, a starvation therapy strate...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Wang Wang, Danni Shan, Guanyi Wang, Xiongmin Mao, Wenjie You, Xiaolong Wang, Zijian Wang
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2024-02-01
Цуврал:	Cell Insight
Нөхцлүүд:	Elafibranor Bladder cancer Conditional reprogramming cell Drug development Preclinical study
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S277289272400004X
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!